Lanean...
Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer’s patients in long-term care health facilities
BACKGROUND: Cholinesterase inhibitors can delay the progression of Alzheimer’s disease (AD). Several clinical trials of the drug in moderate to severe AD have consistently reported clinically positive effects. A combining effect with psychosocial intervention was reported in mild to moderate AD pati...
Gorde:
| Argitaratua izan da: | BMC Neurol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4280048/ https://ncbi.nlm.nih.gov/pubmed/25516360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-014-0243-7 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|